JPH07506586A - 新規タキサン誘導体，それらの製造，およびそれらを含む組成物 - Google Patents

新規タキサン誘導体，それらの製造，およびそれらを含む組成物

Info

Publication number
JPH07506586A
JPH07506586A JP5519950A JP51995093A JPH07506586A JP H07506586 A JPH07506586 A JP H07506586A JP 5519950 A JP5519950 A JP 5519950A JP 51995093 A JP51995093 A JP 51995093A JP H07506586 A JPH07506586 A JP H07506586A
Authority
JP
Japan
Prior art keywords
carbon atoms
group
atoms
groups
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5519950A
Other languages
English (en)
Japanese (ja)
Inventor
ブルザ，ジヤン−ドミニク
コメルソン，アラン
Original Assignee
ローン−プーラン・ロレ・ソシエテ・アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ローン−プーラン・ロレ・ソシエテ・アノニム filed Critical ローン−プーラン・ロレ・ソシエテ・アノニム
Publication of JPH07506586A publication Critical patent/JPH07506586A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
JP5519950A 1992-05-21 1993-05-18 新規タキサン誘導体，それらの製造，およびそれらを含む組成物 Pending JPH07506586A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR92/06177 1992-05-21
FR9206177A FR2691460B1 (fr) 1992-05-21 1992-05-21 Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
PCT/FR1993/000477 WO1993023389A1 (fr) 1992-05-21 1993-05-18 Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
JPH07506586A true JPH07506586A (ja) 1995-07-20

Family

ID=9430017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5519950A Pending JPH07506586A (ja) 1992-05-21 1993-05-18 新規タキサン誘導体，それらの製造，およびそれらを含む組成物

Country Status (13)

Country Link
EP (1) EP0641334A1 (OSRAM)
JP (1) JPH07506586A (OSRAM)
KR (1) KR950701629A (OSRAM)
AU (1) AU4075893A (OSRAM)
CA (1) CA2136211A1 (OSRAM)
CZ (1) CZ285294A3 (OSRAM)
FI (1) FI945439A7 (OSRAM)
FR (1) FR2691460B1 (OSRAM)
MX (1) MX9302915A (OSRAM)
SK (1) SK139994A3 (OSRAM)
TW (1) TW227560B (OSRAM)
WO (1) WO1993023389A1 (OSRAM)
ZA (1) ZA933462B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057031A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes as antitumor agents
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
KR20020000159A (ko) 2000-02-02 2002-01-04 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서의 ｃ10 카르바모일옥시 치환된 탁산
PE20050693A1 (es) 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
EP2276755A4 (en) 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES
CN103983627A (zh) * 2008-06-17 2014-08-13 韩国巴斯德研究所 作为抗结核病药的吡啶并嘧啶化合物
WO2011139899A2 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN105294610B (zh) * 2015-07-16 2017-10-31 中国科学院上海药物研究所 7‑epi‑紫杉烷类化合物的制备方法
CN107021943B (zh) * 2016-02-02 2020-12-29 中国科学院上海药物研究所 一类7-epi-巴卡亭III衍生物，及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206221A (en) * 1979-01-03 1980-06-03 The United States Of America As Represented By The Secretary Of Agriculture Cephalomannine and its use in treating leukemic tumors
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
FR2658513B1 (fr) * 1990-02-21 1994-02-04 Rhone Poulenc Sante Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).

Also Published As

Publication number Publication date
SK139994A3 (en) 1995-07-11
TW227560B (OSRAM) 1994-08-01
EP0641334A1 (fr) 1995-03-08
AU4075893A (en) 1993-12-13
ZA933462B (en) 1993-12-14
WO1993023389A1 (fr) 1993-11-25
FI945439L (fi) 1994-11-18
MX9302915A (es) 1993-11-01
FI945439A0 (fi) 1994-11-18
CA2136211A1 (fr) 1993-11-25
FR2691460A1 (fr) 1993-11-26
FR2691460B1 (fr) 1994-07-22
CZ285294A3 (en) 1995-04-12
KR950701629A (ko) 1995-04-28
FI945439A7 (fi) 1994-11-18

Similar Documents

Publication Publication Date Title
KR100500351B1 (ko) 택소이드, 이의 제조방법 및 이를 함유하는 약학 조성물
WO1998008833A1 (en) Sulfenamide taxane derivatives
KR19980703287A (ko) 신규 택소이드, 이의 제조법 및 이를 함유한 약학 조성물
JPH06509107A (ja) タキソール類似体である新規な誘導体、その製造およびこれを含有する組成物
JP2001521493A (ja) ６−ハロ−又はニトレート置換パクリタクセル
JPH08225558A (ja) パクリタクセルのアミノ酸誘導体
JPH07506586A (ja) 新規タキサン誘導体，それらの製造，およびそれらを含む組成物
AU706155B2 (en) 7-deoxy-6-substituted paclitaxels
AP1023A (en) Taxoids, preparation thereof and pharmaceutical compositions containing same.
EP1688415A1 (en) Cytotoxic agents comprising new C-2 modified taxanes
RU2144920C1 (ru) Таксоиды, способ их получения и фармацевтическая композиция на их основе
IL117760A (en) Taxoids, their preparation and pharmaceutical preparations containing them
BG62697B1 (bg) Нови таксоиди, получаването им и фармацевтични състави, които ги съдържат
ES2628022T3 (es) Derivados de camptotecina con actividad antitumoral
US6017935A (en) 7-sulfur substituted paclitaxels
JPH10510811A (ja) 白金およびテルルまたはセレン化合物の併用により腫瘍の発育を減少させる方法および組成物
JP2003520792A (ja) 抗腫瘍活性及び抗脈管形成活性を有する半合成タキサン類
JPH10502088A (ja) ブレフェルジンａの新しい誘導体およびがん治療におけるそれらの有用性
WO1999032109A1 (en) 7-deoxy-6-nitrogen substituted paclitaxels
AU706955B2 (en) 7-O-methoxymethyl paclitaxel
EP1980562A1 (en) Taxol derivatives with antitumor activity
CA2365776A1 (en) Method for treating abnormal cell proliferation in the brain
HK1017895B (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same